by HAEMATO AG | Dec 15, 2020 | Allgemein, Investor News
HAEMATO AG acquires “M1 Aesthetics GmbH” from M1 Kliniken AG – Contribution of the company within the scope of a capital increase in kind of HAEMATO AG Berlin, 15.12.2020 – M1 Kliniken AG and HAEMATO AG today signed a contract for the...
by Haemato AG | Aug 24, 2020 | Allgemein
In the first half of 2020, HAEMATO AG achieved an EBITDA of EUR 2,066 thousand. Sales amounted to EUR 115.8 million. In the first six months of the financial year 2020, HAEMATO AG, Berlin (ISIN: DE0006190705) achieved an IFRS group sales of EUR 115.8 million (previous...
by Haemato AG | Jun 25, 2020 | Ad-Hoc Announcement, Allgemein, Investor News
HAEMATO AG: The Supervisory Board and the Executive Board have agreed that Mr Uwe Zimdars will leave the Executive Board of HAEMATO AG on June 30, 2020. Mr Zimdars is currently Executive Board Member of HAEMATO AG and Supervisory Board Member of M1 Kliniken AG. Due to...
by Haemato AG | Nov 25, 2019 | Allgemein
In the third quarter of 2019 HAEMATO AG, Berlin (ISIN: DE0006190705), achieved IFRS consolidated revenues of EUR 47.8 million. In the considered period from January to Sep-tember 2019 the sales totaled EUR 141.8 million (previous year: EUR 212.8 million). The EBITDA...
by Haemato AG | Aug 26, 2019 | Allgemein
In the first half of 2019, HAEMATO AG achieved EBITDA of EUR 1.69 million. Sales amounted to EUR 94.0 million. In the first six months of the financial year 2019, HAEMATO AG, Berlin (ISIN: DE0006190705), achieved an IFRS consolidated revenue of EUR 94.0 million...